Skip to main content

Table 6 Stability evaluation of SAX and 5-OH SAX (n = 3)

From: Pharmacokinetic/Pharmacodynamic modelling of Saxagliptin and its active metabolite, 5-hydroxy Saxagliptin in rats with Type 2 Diabetes Mellitus

Analytes

Spiked concentration (ng/mL)

Freshly

preparations (%)

Room

temperature for 4 h (%)

4 °C for 12 h (%)

−80 °C for 7 days (%)

Freeze-thaw three cycles (%)

Autosampler at 4 °C for up to 16 h (%)

SAX

15

100.62 ± 3.08

99.02 ± 2.02

100.60 ± 2.29

98.56 ± 2.14

96.71 ± 1.93

99.02 ± 2.00

2000

98.99 ± 2.10

99.59 ± 3.47

99.09 ± 2.02

98.07 ± 2.07

95.84 ± 1.52

98.05 ± 2.04

5-OH SAX

3

100.67 ± 4.16

99.78 ± 2.22

100.67 ± 2.52

95.11 ± 4.55

94.89 ± 2.91

100.44 ± 3.10

400

101.04 ± 2.71

98.51 ± 2.19

99.32 ± 2.66

97.49 ± 2.52

95.79 ± 2.16

101.22 ± 2.47